Diroximel Fumarate

Diroximel Fumarate

Cat. No.: PI1577222140

Description: Diroximel fumarate, also known as ALKS-8700, is in Phase III clinical trials for the treatment of relapsing remitting multiple sclerosis, which is the most common form of multiple sclerosis (MS). Relapsing remitting MS is characterized by episodes of worsening neurologic functioning followed by partial or complete recovery periods free of disease progression.

Product Details
CAS 1577222-14-0
Synonyms 4-O-[2-(2,5-dioxopyrrolidin-1-yl)ethyl] 1-O-methyl (E)-but-2-enedioate
Molecular Formula C11H13NO6
Molecular Weight 255.22
Available Formulations Oral Solid
Technology Synthetic
Available DMF/CEP/GMP US DMF
Appearance Solid powder

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to inquiry@alfa-chemistry.com or fill out the following form.

Verification code
For product and service inquiries icon1

For product and service inquiries, please use our online system or send an email to inquiry@alfa-chemistry.com.

For product and service inquiries icon2

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x